Jilin Aodong To Invest 300 Million Yuan In Mining Industry
This article was originally published in PharmAsia News
Executive SummaryJilin Aodong Medicine Industry Group has allocated 309 million yuan ($44 million) to purchase Tianchi Industry & Trading Company's 30 percent share in Dunhua Tadong Mining Company-part of Tong Steel Group-and further increase stake in the mining firm. Jilin Aodong says that the investment amount accounts for only 6.71 percent of its 2007 unaudited net assets, thus will not have a major impact on its financials. In fact, the corporation believes the acquisition will greatly help its long-term development if successful. On the other hand, Jilin Aodong faces multiple risks in areas such as market, technology, environment protection, project management and internationally influenced iron ore pricing. (Click her for more - Chinese language)
You may also be interested in...
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced January 2020.
Industry experts expect a continued uptick in deals valued between $2bn-$10bn this year as buyers look to add critical mass in areas like oncology, rare disease and cell and gene therapy. Divestitures to free up capital and narrow focus should continue too.
UK-centric investment firm Syncona’s model of “founding, building and funding” early-stage biotech companies – with a commitment to the longer term – hopes to help make Great Britain a cell and gene therapy powerhouse.